Charlotte Lindsay

I am a Clinical Research Fellow at the Centre for Trauma Sciences and Emergency Medicine Registrar in the East of England. I studied medicine at the Norwich Medical School and completed my foundation training in East Anglia before entering emergency medicine training where I discovered a love of paediatrics.
I completed the MSc in Trauma Sciences at Queen Mary University of London where I was struck by a lack of specific evidence to characterise the paediatric response to injury or guide management of trauma and haemorrhage in children. This inspired me to pursue a career in research and I joined the Centre for Trauma Sciences in 2019.
My research focus is on understanding the coagulopathy of traumatic brain injury to aid diagnosis and identify potential new treatments to improve outcomes in these patients. I also have an interest in changes in coagulation and inflammation in children after injury.
I am currently the Associate PI for the centre’s Activation of Coagulation and Inflammation in Trauma (ACIT) study and have expanded the study to include children, creating one of the first paediatric trauma biobanks in the world.
In addition to my research, I have co-led on a public engagement module with the Centre’s Trauma Science and Care of the Injured Patient Programme' (TSCIPP) students where students develop and deliver public engagement activities to raise awareness of our research and inspire the next generation of scientists.
Contact: c.lindsay@qmul.ac.uk
- Fernandes K, Davenport R, Cole E et al. (2024). 2961 Little bleeders: characterising a paediatric major haemorrhage population. a6.1-a6a6.
10.1136/emermed-2024-rcem.11 - Lindsay C, Davenport R, Baksaas-Aasen K et al. (2024). Correction of Trauma-induced Coagulopathy by Goal-directed Therapy: A Secondary Analysis of the ITACTIC Trial. Anesthesiology 141, (5) 904-912.
10.1097/aln.0000000000005183 - Piercy J, Lindsay C, Davenport R (). Can We Help Stop Bleeding in Badly Injured People. Frontiers for Young Minds 12.
10.3389/frym.2024.1352052 - Lindsay C, Green L, Henry J et al. (2024). Coagulopathy and Prophylaxis of Venous Thromboembolism in Traumatic Brain Injury. 331-345.
10.1007/978-3-031-50117-3_19 - Schofield H, Lindsay C, Brohi K et al. (2024). Group B or not group B? An association between ABO, early mortality, and organ dysfunction in major trauma patients with shock. Journal of Thrombosis and Haemostasis 22, (3) 676-685.
10.1016/j.jtha.2023.11.018 - Lindsay C, Davenport R, Brohi K (2023). 2347 Traumatic brain injury coagulopathy is associated with raised intracranial pressure, 7-day progression of haemorrhage and mortality. 870.2-87871.
10.1136/emj-2023-rcem.20 - Hannadjas I, James A, Davenport R et al. (). Prothrombin complex concentrate (PCC) for treatment of trauma-induced coagulopathy: systematic review and meta-analyses. Critical Care 27, (1) 422-.
10.1186/s13054-023-04688-z - Ross J, Bocchetta N, Hickey H et al. (2023). 6 Beyond the default male: exploring sex differences in the acute physiological response to trauma and associated clinical outcomes. BMJ Military Health 169, (3) e3.6-.
10.1136/bmjmilitary-2023-rsmabstracts.6 - Abani O, Abbas A, Abbas F et al. (2023). Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet 401, (10387) 1499-1507.
10.1016/s0140-6736(23)00510-x - Ross J, Bocchetta N, Hickey H et al. (2022). 1795 Beyond the default male: exploring sex differences in the acute physiological response to trauma and associated clinical outcomes. Emergency Medicine Journal 39, (12) a971.1-a9a971.
10.1136/emermed-2022-rcem2.16 - Abani O, Abbas A, Abbas F et al. (2022). Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. The Lancet 400, (10349) 359-368.
10.1016/s0140-6736(22)01109-6 - Abani O, Abbas A, Abbas F et al. (2022). Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet 399, (10325) 665-676.
10.1016/s0140-6736(22)00163-5 - Abani O, Abbas A, Abbas F et al. (2022). Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet 399, (10320) 143-151.
10.1016/s0140-6736(21)01825-0 - Group RC (2021). Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Respiratory Medicine 9, (12) 1419-1426.
10.1016/s2213-2600(21)00435-5 - Cottey L, Roberts T, Graham B et al. (2021). Need for recovery and physician well-being in emergency departments: national survey findings. European Journal of Emergency Medicine 28, (5) 386-393.
10.1097/mej.0000000000000850 - Abani O, Abbas A, Abbas F et al. (2021). Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. The Lancet 397, (10289) 2049-2059.
10.1016/s0140-6736(21)00897-7 - Abani O, Abbas A, Abbas F et al. (2021). Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet 397, (10285) 1637-1645.
10.1016/s0140-6736(21)00676-0 - Cottey L, Roberts T, Graham B et al. (2020). Need for recovery amongst emergency physicians in the UK and Ireland: a cross-sectional survey. BMJ Open 10, (11) e041485-.
10.1136/bmjopen-2020-041485 - Lindsay C, Broad E (2018). G332 Acute traumatic coagulopathy in the paediatric population: a systematic review. Archives of Disease in Childhood 103, (Suppl 1) a134-a135.
10.1136/archdischild-2018-rcpch.322

